Regeneron (REGN) Announces FDA Approval of Libtay in Combination with Chemotherapy for Treatment for Advanced Non-small Cell Lung Cancer (NSCLC)

Press/Media

Period	9 Nov 2022

Media coverage

Title	Regeneron (REGN) Announces FDA Approval of Libtay in Combination with Chemotherapy for Treatment for Advanced Non-small Cell Lung Cancer (NSCLC)
Media name/outlet	Street Insider
Country/Territory	United States
Date	9/11/22
URL	ct.moreover.com/?a=49208315438&p=1gw&v=1&x=_01rm8cZbtr6wdlB9woTcQ
Persons	Israel Lowy,